AAAAAA
Results: 51-75/113
Authors:
Kahle, PJ
Jakowec, M
Teipel, SJ
Hampel, H
Petzinger, GM
Di Monte, DA
Silverberg, GD
Moller, HJ
Yesavage, JA
Tinklenberg, JR
Shooter, EM
Murphy, GM
Citation: Pj. Kahle et al., Combined assessment of tau and neuronal thread protein in Alzheimer's disease CSF, NEUROLOGY, 54(7), 2000, pp. 1498-1504
Authors:
Moller, HJ
Citation: Hj. Moller, Current assessment of new/atypical neuroleptics, NERVENARZT, 71(5), 2000, pp. 329-344
Authors:
Moller, HJ
Citation: Hj. Moller, Results and methodological problems in the evaluation of newer atypical neuroleptics in the treatment of schizophrenic negative symptoms, NERVENARZT, 71(5), 2000, pp. 345-353
Authors:
Krupinski, M
Fischer, A
Grohmann, R
Engel, RR
Hollweg, M
Moller, HJ
Citation: M. Krupinski et al., Schizophrenic psychoses and inpatient suicide: risk factors and psychopharmocological treatment, NERVENARZT, 71(11), 2000, pp. 906
Authors:
Hegerl, U
Moller, HJ
Citation: U. Hegerl et Hj. Moller, Pharmacotherapy of depression in oldage, NERVENARZT, 71(1), 2000, pp. 1-8
Authors:
Moller, HJ
Citation: Hj. Moller, Modern pharmacotherapy for depression, INTERNIST, 41(1), 2000, pp. 70-79
Authors:
Meisenzahl, EM
Frodl, T
Zetzsche, T
Leinsinger, G
Heiss, D
Maag, K
Hegerl, U
Hahn, K
Moller, HJ
Citation: Em. Meisenzahl et al., Adhesio interthalamica in male patients with schizophrenia, AM J PSYCHI, 157(5), 2000, pp. 823-825
Authors:
Moller, HJ
Bottlender, R
Wegner, U
Wittmann, J
Strauss, A
Citation: Hj. Moller et al., Long-term course of schizophrenic, affective and schizoaffective psychosis: focus on negative symptoms and their impact on global indicators of outcome, ACT PSYC SC, 102, 2000, pp. 54-57
Authors:
Moller, HJ
Citation: Hj. Moller, Amisulpride: a review of its efficacy in schizophrenia, ACT PSYC SC, 101, 2000, pp. 17-22
Authors:
Bottlender, R
Strauss, A
Moller, HJ
Citation: R. Bottlender et al., Prevalence and background factors of depression in first admitted schizophrenic patients, ACT PSYC SC, 101(2), 2000, pp. 153-160
Authors:
Hampel, H
Padberg, F
Buch, K
Unger, J
Stubner, S
Moller, HJ
Citation: H. Hampel et al., Diagnosis and treatment of Alzheimer-type dementia, DEUT MED WO, 124(5), 1999, pp. 124-129
Authors:
Burns, A
Rossor, M
Hecker, J
Gauthier, S
Petit, H
Moller, HJ
Rogers, SL
Friedhoff, LT
Citation: A. Burns et al., The effects of donepezil in Alzheimer's disease - Results from a multinational trial, DEMENT G C, 10(3), 1999, pp. 237-244
Authors:
Ehrhardt, T
Plattner, A
Padberg, F
Moller, HJ
Hampel, H
Citation: T. Ehrhardt et al., Behavioral treatment of a patient with early-stage Alzheimer's disease, VERHALTENST, 9(3), 1999, pp. 154-161
Authors:
Fichter, MM
Heuser, J
Hiller, W
Moller, HJ
Rief, W
Schweiger, U
Citation: Mm. Fichter et al., Editorial - Seventh Congress of the German Society for Behavioral Medicineand Behavioral Modification in Prien, March 10-13, VERHALTENST, 9, 1999, pp. V-VI
Authors:
Moller, HJ
Citation: Hj. Moller, Forum - Psychiatry and the neurosciences - Commentary, CUR OPIN P, 12(6), 1999, pp. 641-642
Authors:
Meisenzahl, EM
Frodl, T
Greiner, J
Leinsinger, G
Maag, KP
Heiss, D
Hahn, K
Hegerl, U
Moller, HJ
Citation: Em. Meisenzahl et al., Corpus callosum size in schizophrenia - a magnetic resonance imaging analysis, EUR ARCH PS, 249(6), 1999, pp. 305-312
Authors:
Muller, H
Moller, HJ
Stippel, A
Fric, M
Grunwald, F
Laux, G
Klemm, E
Biersack, HJ
Citation: H. Muller et al., SPECT patterns in probable Alzheimer's disease, EUR ARCH PS, 249(4), 1999, pp. 190-196
Authors:
Moller, HJ
Muller, N
Citation: Hj. Moller et N. Muller, Schizophrenia: Basic research and therapeutical implications - Preface, EUR ARCH PS, 249, 1999, pp. 1-1
Authors:
Bottlender, R
Wegner, U
Wittmann, J
Strauss, A
Moller, HJ
Citation: R. Bottlender et al., Deficit syndromes in schizophrenic patients 15 years after their first hospitalisation: preliminary results of a follow-up study, EUR ARCH PS, 249, 1999, pp. 27-36
Authors:
Moller, HJ
Citation: Hj. Moller, Atypical neuroleptics: a new approach in the treatment of negative symptoms, EUR ARCH PS, 249, 1999, pp. 99-107
Authors:
Kleindienst, N
Greil, W
Ruger, B
Moller, HJ
Citation: N. Kleindienst et al., The prophylactic efficacy of lithium - transient or persistent?, EUR ARCH PS, 249(3), 1999, pp. 144-149
Authors:
Moller, HJ
Muller, N
Citation: Hj. Moller et N. Muller, Dementia: Traditional and modern aspects - Preface, EUR ARCH PS, 249, 1999, pp. 1-2
Authors:
Kasper, S
Moller, HJ
Citation: S. Kasper et Hj. Moller, Benefit-risk evaluation of olanzapine, risperidone and sertindole in the treatment of schizophrenia, EUR ARCH PS, 249, 1999, pp. 1-1
Authors:
Kasper, S
Hale, A
Azorin, JM
Moller, HJ
Citation: S. Kasper et al., Benefit-risk evaluation of olanzapine, risperidone and sertindole in the treatment of schizophrenia, EUR ARCH PS, 249, 1999, pp. 2-14
Authors:
Moller, HJ
Citation: Hj. Moller, Reappraising neurotransmitter-based strategies, EUR NEUROPS, 9, 1999, pp. S53-S59